Biotic supplements might not be enough without ‘gut conditioning’, Dr. Wilbert Sybesma, founder of consultancy firm Microbiome Solutions told the audience at NutraIngredients' Probiota event earlier this month.
dsm-firmenich plans to separate out the animal nutrition arm of its firm in an aim to reduce exposure to vitamin price volatility and focus on nutrition, health, and beauty.
DSM has “refined and scaled” its proprietary manufacturing process for fully bio-based vitamin A and will initiate commercial-scale production in 2023.
DSM, Unilever and Google are among a number of global organisations who have contributed to a publication describing how to improve nutrition in the workplace.
DSM and Firmenich’s mooted 2023 ‘Merger of Equals’ will create a nutrition, food ingredients and fragrances behemoth with 277 years of collective business experience and a combined annual revenue pushing towards €12 billion (£10.2bn).
Nutrition giants DSM have renewed their partnership with UNICEF and nutrition think tank and incubator Sight and Life that seeks to improve nutrition for at-risk groups in Sub Saharan Africa and Asia.
The ‘great resignation’ appears to continue unabated with the nutrition industry being no exception. Here, NutraIngredients rounds up the moves made for March and April.
Royal DSM, a Dutch-headquartered global company, has revealed a new integrated Food & Beverage operating structure which unifies three areas of DSM’s nutrition business – Food Specialties, Hydrocolloids and part of its Nutritional Products group.
Age-related loss of appetite (or anorexia of ageing) is a primary cause of malnutrition in the elderly, which has a direct impact on the body’s ability to fight infections in later life, according to a DSM Whitepaper ‘Supporting optimal immune function...
DSM continue to develop its interests in plant-based proteins as the corporation confirms the purchase of pea and bean ingredient specialists Vestkorn Milling for €65m.
The European Food Safety Authority (ESFA) has taken the month of July to give its scientific opinion on a number of dietary supplement ingredients following requests from the European Commission.
DSM is to move its global head office from Heerlen to Maastricht by the end of 2023 in a move that has ‘employee wellbeing’ and ‘sustainability’ at its heart.
Global food and nutritional ingredients supplier DSM continues to make substantial investment in Eastern Europe with the opening of its new extended manufacturing facility in Poland.
DSM’s new venture Hologram Sciences plans to run a blood sugar management trial in Singapore to study how personalised approaches can help address pre-diabetes concerns, we can exclusively reveal.
Ingredients giant DSM has teamed up with San Diego-based startup Debut Biotech to explore the potential of its ‘cell-free’ biomanufacturing platform, a next-generation manufacturing process it claims could unlock new opportunities to biosynthesize a far...
April 2021 and the COVID-19 saga continues to rumble on with news of an impending third wave throughout Europe. Despite plans to restrict movement, the rules don’t appear to have affected recruitment as NutraIngredients rounds up March’s movers and shakers.
DSM has today (31 March) agreed to acquire the flavour and fragrance (F&F) business of US-based biotech firm Amyris, extending its portfolio with bio-based ingredients for the flavor and fragrance and cosmetics industries.
When much of Europe is in lockdown, finding the next step up the career ladder seems like time well spent. As opportunity knocks, NutraIngredients rounds up January’s movers and shakers.
With the digi-ink still drying on its freshly minted pro cycling sponsorship, nutritionals giant Royal DSM is demonstrating its commitment to sports nutrition and personalised nutrition.
The potential health effects of human milk oligosaccharides (HMOs) for adults may extend beyond just promoting the growth of beneficial Bifidobacteria to also impacting immune function and the gut barrier, says a new study.
This Summer sees nutrition and ingredient firms continue to make a number of appointments as the ongoing pandemic threatens to halt recruitment in various industry sectors.
NutraIngredients presents a roundup of this month’s key moves...
DSM Venturing has taken part in a €10m funding round that backs the efforts of British life science company Phynova and its mulberry leaf extract ingredient that addresses blood glucose levels.
The European Commission (EC) is to allow lacto-N-tetraose (LNT) to be placed on the market as a Novel Food for use in food supplements and infant product formulations.
Supplement manufacturers and suppliers in China sought return to normalcy as they resume operations as the extended Chinese New Year holiday – lengthened by the novel coronavirus outbreak – comes to an end.
New products and solutions for personalisation and fortification are key priorities for DSM in APAC for 2020, in order to meet the highly diverse needs of consumers across the region.
Royal DSM and French chemical company Metex NØØvista, are to partner up in a research and development deal to deliver a 100% bio-sourced ingredient for skincare products.
Personalised nutrition ‘is the future’ for dietary supplements, but there still needs to be major advances in testing, product formulation and consumer feedback before it can become a mainstream solution.
DSM said it was striving to work with manufacturers to tap into the rising trend of snacking and increasing number of convenience stores, in order to make nutritional products more affordable and accessible.
DSM reported above market volume and sales gains for Q1 2018 with strong performance in its underlying nutrition business, which grew 5% in volume compared to the same period last year driven by strong sales in its i-Health and vitamin pre-mix businesses....
DSM has completed a major milestone in its restructuring into a smaller, more profitable and more focused company as it finalized the sale of its pharmaceutical manufacturing assets to US-based Thermo Fisher Scientific Inc.
DSM has dubbed its forthcoming Innovation Partnering Conference a "win-win" for itself and nutrition entrepreneurs as it looks to unearth the rising stars of fermented foods and bio-preservation.
Weight is the top health concern for adults overall, while Russians have their eye on age-related loss of vision, a DSM survey of 7,000 people across Europe, the Middle East and Africa has revealed.
DSM has been named as one of its sector’s leaders in environmental prudence in the Dow Jones Sustainability World Index, but the company says it sees such lists as a means, not an end.
Dutch nutrition firm DSM has applied for an EU health claim on DHA and “improved memory function” – but is it likely to succeed and what would it bring to the nutrition landscape if it did?
Consumers who are seeking to limit their exposure to gluten have another line of defense in a new product released by DSM. Called Tolerase G, the enzyme can serve to break down residual gluten in a meal before it can cause a reaction, the company said.
DSM Nutritional Products (DNP) wants to engage with commercial, government and academic entities at a 2-day open innovation (OI) summit with selected participants in December.
Mid-last year the chief of Norwegian omega-3 player EPAX told us, “We are the last of the big omega-3 independents.” Soon after US agri-food company FMC had snapped it up for $350m. Here FMC Nutraceuticals general manager Daniel H. Rosenbaum talks through...
The Natural Algae Astaxanthin Association (NAXA) has again questioned the quality and regulatory status of DSM’s synthetic astaxanthin ingredient, with new data reportedly showing ‘vastly inferior antioxidant potential’ compared with the natural, algae-derived...
One year on from its acquisition of Swedish beta-glucan brand OatWell, DSM talks about entering into new markets and capitalizing on European health claims.
DSM has delivered a Q3 increase in EBITDA earnings of 27% across all its divisions despite “headwinds” like the ongoing economic flatline in Europe and elsewhere, challenging currency movements and rising ingredient costs.
Organic growth and a healthy boost from last year’s €500m Fortitech investment lifted Q2 pre-tax profits 19% to €345m at Dutch ingredients and chemicals giant, Royal DSM.
